Our clinical trial enrolled postmenopausal women with osteopenia. However, the bone cells and mechanisms involved in stimulating improvements in bone density are consistent in osteopenia and osteoporosis. Please talk to your doctor, who can advise what is best for your specific bone health situation. Healthcare providers should consider Osteoboost's full Indications for Use when determining whether it is appropriate for an individual patient. Clinical trials of Osteoboost reported no serious device-related adverse events or severe health risks.
